Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
228.8 USD | -0.68% | -3.52% | -6.17% |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The company is in debt and has limited leeway for investment
- With an expected P/E ratio at 31.89 and 28.45 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3.91 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.17% | 66.12B | A | ||
-5.56% | 181B | C+ | ||
-0.11% | 108B | C | ||
+2.64% | 50.65B | B- | ||
+6.58% | 43.11B | B- | ||
+3.97% | 41.3B | B+ | ||
+21.98% | 31.6B | B | ||
+16.38% | 25.03B | A- | ||
-5.81% | 24.16B | A- | ||
-4.35% | 23.95B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BDX Stock
- Ratings Becton, Dickinson and Company